CASIF
CASI Pharmaceuticals, Inc.
$0.12
0.00 (0.00%) Today
— up— down
Open
$0.12
$0.12Previous Close
$0.12
$0.12Day Range
$0.12 – $0.12
$0.12 – $0.1252-Week Range
$0.05 – $3.09
$0.05 – $3.09Earnings Date
Aug 27, 2026
Aug 27, 2026Volume
25
25Exchange
OTC Markets OTCQB
OTC Markets OTCQBAbout CASIF
CASI Pharmaceuticals, previously known as EntreMed is a US based pharmaceutical company developing medicinal treatments for cancer. The company is primarily known for its producing the angiogenesis inhibitor Endostatin. In 2014 the company was renamed to CASI Pharmaceuticals to focus on products for the treatments of myeloma, leukemia, lymphoma. Wei-Wu He is the present chairman and CEO of the company.
Related
News
Buffett delays annual donation to Gates Foundation pending review of Jeffrey Epstein ties: WSJ
CNBC · 1h ago
UK economy grows as expected before Iran war impact, ONS data shows - Reuters
Reuters · 3h ago
Oil set for steepest quarterly loss since 2020 as traders focus on US-Iran talks - Reuters
Reuters · 8h ago
Trump urges gasoline retailers to lower prices, warns of 'big problems' if they don't - Reuters
Reuters · 9h ago
Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump - Reuters
Reuters · 10h ago